FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Jan 31, 2013
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on January 31, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA Inc
- Inspection Date
- January 31, 2013
- Product Type
- Biologics
View Company Profile
ID · d2c1d5c1-19fb-4f0c-84c2-1347515a3439
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 816496
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 20, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 11, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 20, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 20, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1114622 - 2019-12-20
- FDA Inspection 1041173 - 2018-02-02
- FDA Inspection 913423 - 2015-02-11
- FDA Inspection 706463 - 2011-01-20
- FDA Inspection 694728 - 2010-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.